Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER in Japanese and Korean patients with cancer pain
NCT01165281Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Countries
- 2
01
Overview
A Phase 3 trial of tapentadol in cancer pain, sponsored by Janssen Pharmaceutical. Started Aug 2010; status: completed.
02
Drugs
tapentadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01165281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165281.